Canadian discovery may soon lead to the prevention of cardiac fibrosis
Groundbreaking research from the University of Alberta and McGill University has opened the door towards the future prevention of cardiac fibrosis—a condition leading to heart failure for which there is currently no treatment.
McGill Newsroom
Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications
Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.
